Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition

Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 12; no. 8; p. 2300
Main Authors Gaballa, Rofaida, Ali, Hamdy E. A., Mahmoud, Mohamed O., Rhim, Johng S., Ali, Hamed I., Salem, Heba F., Saleem, Mohammad, Kandeil, Mohamed A., Ambs, Stefan, Abd Elmageed, Zakaria Y.
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 15.08.2020
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells.
AbstractList Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells.
Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells.Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells.
Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-[beta]-cyclodextrin (M[beta]CD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells.
Audience Academic
Author Gaballa, Rofaida
Salem, Heba F.
Ali, Hamdy E. A.
Rhim, Johng S.
Kandeil, Mohamed A.
Saleem, Mohammad
Ambs, Stefan
Ali, Hamed I.
Abd Elmageed, Zakaria Y.
Mahmoud, Mohamed O.
AuthorAffiliation 1 Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M Health Science Center, College Station, TX 77843, USA; Rofayda011142@pharm.bsu.edu.eg (R.G.); haali@tamu.edu (H.E.A.A.); alyismail@tamu.edu (H.I.A.)
3 Department of Radiobiological Applications, Nuclear Research Center, Atomic Energy Authority, Cairo 13759, Egypt
5 Department of Pharmaceutics, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62521, Egypt; heba_salem2004@yahoo.co.uk
2 Departments of Biochemistry, Faculty of Pharmacy, Beni-Suef University; Beni-Suef 62521, Egypt; mohamed.omar@pharm.bsu.edu.eg
4 Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; jrhim@verizon.net
8 Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA; ambss@mail.nih.gov
9 Department of Pharmacology, Edward Via College of Osteopathic Medicine, University of Louisiana at Monroe, Monroe, LA 71203, USA
6 Department of
AuthorAffiliation_xml – name: 3 Department of Radiobiological Applications, Nuclear Research Center, Atomic Energy Authority, Cairo 13759, Egypt
– name: 1 Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M Health Science Center, College Station, TX 77843, USA; Rofayda011142@pharm.bsu.edu.eg (R.G.); haali@tamu.edu (H.E.A.A.); alyismail@tamu.edu (H.I.A.)
– name: 5 Department of Pharmaceutics, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62521, Egypt; heba_salem2004@yahoo.co.uk
– name: 9 Department of Pharmacology, Edward Via College of Osteopathic Medicine, University of Louisiana at Monroe, Monroe, LA 71203, USA
– name: 4 Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; jrhim@verizon.net
– name: 7 Department of Biochemistry, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62521, Egypt; mohamedkandeel561@yahoo.com
– name: 8 Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA; ambss@mail.nih.gov
– name: 6 Department of Urology, Masonic Cancer Center, University of Minnesota, Minnesota, MN 55455, USA; msbhat@umn.edu
– name: 2 Departments of Biochemistry, Faculty of Pharmacy, Beni-Suef University; Beni-Suef 62521, Egypt; mohamed.omar@pharm.bsu.edu.eg
Author_xml – sequence: 1
  givenname: Rofaida
  orcidid: 0000-0003-1387-2118
  surname: Gaballa
  fullname: Gaballa, Rofaida
– sequence: 2
  givenname: Hamdy E. A.
  orcidid: 0000-0003-3290-1623
  surname: Ali
  fullname: Ali, Hamdy E. A.
– sequence: 3
  givenname: Mohamed O.
  surname: Mahmoud
  fullname: Mahmoud, Mohamed O.
– sequence: 4
  givenname: Johng S.
  surname: Rhim
  fullname: Rhim, Johng S.
– sequence: 5
  givenname: Hamed I.
  surname: Ali
  fullname: Ali, Hamed I.
– sequence: 6
  givenname: Heba F.
  surname: Salem
  fullname: Salem, Heba F.
– sequence: 7
  givenname: Mohammad
  orcidid: 0000-0002-7422-7967
  surname: Saleem
  fullname: Saleem, Mohammad
– sequence: 8
  givenname: Mohamed A.
  surname: Kandeil
  fullname: Kandeil, Mohamed A.
– sequence: 9
  givenname: Stefan
  surname: Ambs
  fullname: Ambs, Stefan
– sequence: 10
  givenname: Zakaria Y.
  orcidid: 0000-0003-4031-0348
  surname: Abd Elmageed
  fullname: Abd Elmageed, Zakaria Y.
BookMark eNp1kstu3CAUhlGVqknTrLtF6qYbJ1xsbDaVotG0GSlRu0jXCHPxENkwBRxlXqFPXZyJehmpbOCI7__POXDeghMfvAHgPUaXlHJ0paRXJiZMUEcoQq_AGUEtqRjj9clf51NwkdIDKotS3LL2DTilpCM1oc0Z-Ll-CilMJlV3RjuZjYb3UfpkTYTBwk0eJIHfYphCNgneuSHK7IKH0mu48Y8yLUEBC5JykcPVc1FwZcYxwX5fID0r5we43rm8NaOTY0mVjFfb_STHQza3eL4Dr60ck7l42c_B98_r-9VNdfv1y2Z1fVupmpNcMamUNlxbzDmyiGDSNwgRiRWpO037VrdKYUt6Urdtj01jW2S1rHlHGeHG0nPw6eC7m_vJaGV8jnIUu-gmGfciSCf-vfFuK4bwKNqaMYxpMfj4YhDDj9mkLCaXVGlYehPmJEhNWY0Qb5qCfjhCH8IcfWlvoRqGSFPzP9QgRyOct6HkVYupuGaUc8abtivU1YFS5a1TNPZ3yRiJZSDE0UAURXOkUC4__1_xd-N_db8AEUm-Ag
CitedBy_id crossref_primary_10_1016_j_jksus_2023_102864
crossref_primary_10_1016_j_prp_2022_154024
crossref_primary_10_3389_fnmol_2021_809878
crossref_primary_10_1186_s40364_022_00398_w
crossref_primary_10_3390_cancers13205236
crossref_primary_10_3390_biom14080990
crossref_primary_10_3389_fbioe_2024_1444201
crossref_primary_10_1007_s12672_024_01183_x
crossref_primary_10_1016_j_critrevonc_2021_103565
crossref_primary_10_1111_and_14079
crossref_primary_10_1186_s12935_023_02935_5
crossref_primary_10_1186_s13045_022_01305_4
crossref_primary_10_20517_cdr_2023_17
crossref_primary_10_3390_cancers16132462
crossref_primary_10_1002_mco2_70009
crossref_primary_10_3390_ijms22073528
crossref_primary_10_3390_cells10051029
crossref_primary_10_3390_cells11091375
crossref_primary_10_3389_fcell_2021_679527
crossref_primary_10_3389_fmolb_2021_708779
crossref_primary_10_1016_j_addr_2023_115054
crossref_primary_10_1016_j_jconrel_2023_07_059
crossref_primary_10_62347_XXXA3182
crossref_primary_10_1016_j_semcancer_2021_08_004
crossref_primary_10_62347_JWMX3035
crossref_primary_10_3389_fgene_2023_1045061
crossref_primary_10_3390_ijms22042193
crossref_primary_10_12677_ACM_2020_1012436
crossref_primary_10_1038_s41388_021_01948_6
crossref_primary_10_1515_cclm_2020_1685
crossref_primary_10_3390_biomedicines12010079
crossref_primary_10_1016_j_heliyon_2023_e23553
crossref_primary_10_1016_j_critrevonc_2024_104348
crossref_primary_10_7554_eLife_59442
crossref_primary_10_1038_s41586_022_04833_8
crossref_primary_10_1186_s12951_023_02219_0
crossref_primary_10_1016_j_prp_2024_155484
crossref_primary_10_1016_j_jddst_2022_103856
crossref_primary_10_1007_s13402_022_00731_3
crossref_primary_10_1080_14728222_2023_2293757
crossref_primary_10_1002_minf_202060040
crossref_primary_10_1007_s11010_023_04715_1
crossref_primary_10_1016_j_canlet_2022_215809
crossref_primary_10_1080_21691401_2023_2238756
crossref_primary_10_1038_s41580_024_00777_1
crossref_primary_10_1186_s12951_025_03326_w
crossref_primary_10_1016_j_cpt_2024_04_005
Cites_doi 10.1002/ijc.26224
10.1038/nature15756
10.1038/nrclinonc.2014.87
10.1002/pros.23446
10.3390/cancers12071870
10.1186/s13058-016-0725-1
10.3390/cells9030564
10.1158/1078-0432.CCR-16-2180
10.1158/1541-7786.MCR-16-0058
10.1158/1541-7786.MCR-08-0400
10.1371/journal.pone.0024234
10.1016/j.ceb.2011.03.014
10.1016/S0002-9440(10)63112-4
10.1371/journal.pone.0135128
10.1158/0008-5472.CAN-16-0543
10.1038/35094009
10.3390/cells9040861
10.1038/srep40464
10.3322/caac.21590
10.1093/carcin/bgt156
10.1038/s41568-018-0038-z
10.1158/0008-5472.CAN-08-2764
10.1158/1055-9965.EPI-18-1132
10.14348/molcells.2016.0210
10.1158/0008-5472.CAN-05-4000
10.1186/s12575-018-0073-x
10.1016/j.matbio.2018.05.002
10.1038/s41598-018-34637-8
10.1186/s13046-019-1496-1
10.3389/fonc.2020.00308
10.1158/0008-5472.CAN-08-0249
10.1016/j.semcancer.2017.02.006
10.1016/j.tcb.2014.12.006
10.1016/j.euf.2017.10.014
10.3390/cancers11101418
10.3402/jev.v2i0.22097
10.1074/jbc.M112.445403
10.1038/nature14492
10.1084/jem.20190158
10.1002/stem.1619
10.1073/pnas.86.24.9906
10.1155/2015/481493
10.1016/j.jamcollsurg.2017.12.040
10.1158/0008-5472.CAN-17-2341
10.20517/2394-4722.2017.32
10.1056/NEJMp048178
10.1038/nm972
10.1016/j.matbio.2018.08.004
10.1016/0046-8177(93)90033-D
10.1186/s12943-016-0523-5
10.1186/1476-4598-13-208
10.2217/fon.10.48
10.1677/ERC-08-0019
10.1002/cncr.10788
10.4103/1477-3163.48453
10.1593/neo.08380
10.1210/en.2013-1971
10.1016/j.matbio.2018.03.009
ContentType Journal Article
Copyright COPYRIGHT 2020 MDPI AG
2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 by the authors. 2020
Copyright_xml – notice: COPYRIGHT 2020 MDPI AG
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 by the authors. 2020
DBID AAYXX
CITATION
3V.
7T5
7TO
7XB
8FE
8FH
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
GUQSH
H94
HCIFZ
LK8
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/cancers12082300
DatabaseName CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection (ProQuest)
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Biological Science Collection
Research Library
Biological Science Database
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2072-6694
ExternalDocumentID PMC7466113
A639969578
10_3390_cancers12082300
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
53G
5VS
8FE
8FH
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
ESX
GNUQQ
GUQSH
GX1
HCIFZ
HYE
IAO
IHR
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RPM
TUS
3V.
7T5
7TO
7XB
8FK
H94
MBDVC
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c492t-6accde9df1990f0212b5002a1c248d3b7d7cc1f2b2477b1e5f70fda4983629ef3
IEDL.DBID M48
ISSN 2072-6694
IngestDate Thu Aug 21 14:11:33 EDT 2025
Thu Jul 10 18:33:26 EDT 2025
Fri Jul 25 11:51:35 EDT 2025
Tue Jun 17 21:31:06 EDT 2025
Tue Jul 01 01:52:02 EDT 2025
Thu Apr 24 23:04:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c492t-6accde9df1990f0212b5002a1c248d3b7d7cc1f2b2477b1e5f70fda4983629ef3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4031-0348
0000-0003-1387-2118
0000-0002-7422-7967
0000-0003-3290-1623
OpenAccessLink https://www.proquest.com/docview/2435602549?pq-origsite=%requestingapplication%
PMID 32824235
PQID 2435602549
PQPubID 2032421
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7466113
proquest_miscellaneous_2436400955
proquest_journals_2435602549
gale_infotracmisc_A639969578
crossref_primary_10_3390_cancers12082300
crossref_citationtrail_10_3390_cancers12082300
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200815
PublicationDateYYYYMMDD 2020-08-15
PublicationDate_xml – month: 8
  year: 2020
  text: 20200815
  day: 15
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Cancers
PublicationYear 2020
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Ren (ref_26) 2019; 38
Hu (ref_8) 2009; 69
Antonarakis (ref_14) 2016; 14
Cox (ref_18) 2015; 522
Hooker (ref_32) 2019; 28
ref_52
Obinata (ref_34) 2012; 130
Reis (ref_50) 2009; 8
Hoshino (ref_20) 2015; 527
ref_17
Li (ref_48) 2017; 7
Ziaee (ref_38) 2014; 13
Siegel (ref_1) 2020; 70
Stanbrough (ref_9) 2006; 66
Ryu (ref_49) 2016; 39
Cheville (ref_4) 2002; 95
Singh (ref_42) 2016; 14
Allott (ref_55) 2016; 18
Bijnsdorp (ref_43) 2013; 2
Robinson (ref_56) 2011; 23
Bonkhoff (ref_15) 2018; 78
Hutchinson (ref_3) 2014; 11
ref_21
Krishn (ref_40) 2019; 77
McAtee (ref_46) 2019; 78
Kelly (ref_13) 2018; 4
Mirzapoiazova (ref_58) 2015; 2015
ref_28
Hamidi (ref_35) 2018; 18
Bonkhoff (ref_51) 1993; 24
Feldman (ref_12) 2001; 1
Seguin (ref_23) 2015; 25
Dai (ref_47) 2019; 216
Elmageed (ref_29) 2014; 32
Elices (ref_25) 1989; 86
Xiao (ref_22) 2018; 78
Karpf (ref_33) 2009; 7
ref_31
Goel (ref_24) 2008; 15
Svensson (ref_45) 2013; 288
Ivell (ref_54) 2014; 155
Hall (ref_39) 2008; 10
Ali (ref_57) 2018; 8
Elmageed (ref_59) 2018; 226
Steinbichler (ref_19) 2017; 44
Melne (ref_2) 2016; 15
Lu (ref_36) 2016; 76
Montgomery (ref_5) 2008; 68
Lu (ref_41) 2018; 70
Holzbeierlein (ref_10) 2004; 164
ref_44
Debes (ref_7) 2004; 351
Chuang (ref_37) 2018; 20
Chen (ref_6) 2004; 10
Agarwal (ref_11) 2010; 6
Dong (ref_53) 2017; 23
Wang (ref_27) 2020; 10
Moroz (ref_16) 2013; 34
Shephard (ref_30) 2017; 3
References_xml – volume: 130
  start-page: 2240
  year: 2012
  ident: ref_34
  article-title: ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.26224
– volume: 527
  start-page: 329
  year: 2015
  ident: ref_20
  article-title: Tumour exosome integrins determine organotropic metastasis
  publication-title: Nature
  doi: 10.1038/nature15756
– volume: 11
  start-page: 299
  year: 2014
  ident: ref_3
  article-title: Closing the Controversies Gap in Prostate Cancer
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2014.87
– volume: 78
  start-page: 2
  year: 2018
  ident: ref_15
  article-title: Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression
  publication-title: Prostate
  doi: 10.1002/pros.23446
– ident: ref_28
  doi: 10.3390/cancers12071870
– volume: 18
  start-page: 68
  year: 2016
  ident: ref_55
  article-title: Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
  publication-title: Breast Cancer Res.
  doi: 10.1186/s13058-016-0725-1
– ident: ref_31
  doi: 10.3390/cells9030564
– volume: 23
  start-page: 3461
  year: 2017
  ident: ref_53
  article-title: HMGA2-FOXL2 axis regulates metastases and epithelial-to-mesenchymal transition of chemoresistant gastric cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-2180
– volume: 14
  start-page: 1136
  year: 2016
  ident: ref_42
  article-title: Exosome-mediated transfer of alphavbeta3 integrin from tumorigenic to nontumorigenic cells promotes a migratory phenotype
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-16-0058
– volume: 7
  start-page: 523
  year: 2009
  ident: ref_33
  article-title: Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-08-0400
– ident: ref_44
  doi: 10.1371/journal.pone.0024234
– volume: 23
  start-page: 630
  year: 2011
  ident: ref_56
  article-title: The role of beta3-integrins in tumor angiogenesis: Context is everything
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2011.03.014
– volume: 164
  start-page: 217
  year: 2004
  ident: ref_10
  article-title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)63112-4
– ident: ref_52
  doi: 10.1371/journal.pone.0135128
– volume: 76
  start-page: 5163
  year: 2016
  ident: ref_36
  article-title: Alphavbeta6 integrin promotes castrate-resistant prostate cancer through JNK1-mediated activation of androgen receptor
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-16-0543
– volume: 1
  start-page: 34
  year: 2001
  ident: ref_12
  article-title: The development of androgen-independent prostate cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/35094009
– volume: 14
  start-page: 316
  year: 2016
  ident: ref_14
  article-title: Current understanding of resistance to abiraterone and enzalutamide in advanced prostate cancer
  publication-title: Clin. Adv. Hematol. Oncol.
– ident: ref_21
  doi: 10.3390/cells9040861
– volume: 7
  start-page: 40464
  year: 2017
  ident: ref_48
  article-title: Integrin beta4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma
  publication-title: Sci. Rep.
  doi: 10.1038/srep40464
– volume: 70
  start-page: 7
  year: 2020
  ident: ref_1
  article-title: Cancer statistics, 2020
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21590
– volume: 34
  start-page: 2017
  year: 2013
  ident: ref_16
  article-title: High circulating estrogens and selective expression of ERbeta in prostate tumors of Americans: Implications for racial disparity of prostate cancer
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgt156
– volume: 18
  start-page: 533
  year: 2018
  ident: ref_35
  article-title: Every step of the way: Integrins in cancer progression and metastasis
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-018-0038-z
– volume: 69
  start-page: 16
  year: 2009
  ident: ref_8
  article-title: Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-2764
– volume: 28
  start-page: 1003
  year: 2019
  ident: ref_32
  article-title: Genetic ancestry analysis reveals misclassification of commonly used cancer cell lines
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-18-1132
– volume: 39
  start-page: 898
  year: 2016
  ident: ref_49
  article-title: Highly expressed integrin-alpha8 induces epithelial to mesenchymal transition-like features in multiple myeloma with early relapse
  publication-title: Mol. Cells
  doi: 10.14348/molcells.2016.0210
– volume: 66
  start-page: 2815
  year: 2006
  ident: ref_9
  article-title: Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-4000
– volume: 20
  start-page: 10
  year: 2018
  ident: ref_37
  article-title: Blockade of ITGA2 induces apoptosis and inhibits cell migration in gastric cancer
  publication-title: Biol. Proced. Online
  doi: 10.1186/s12575-018-0073-x
– volume: 78
  start-page: 165
  year: 2019
  ident: ref_46
  article-title: Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling
  publication-title: Matrix Biol.
  doi: 10.1016/j.matbio.2018.05.002
– volume: 8
  start-page: 16335
  year: 2018
  ident: ref_57
  article-title: Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-34637-8
– volume: 38
  start-page: 485
  year: 2019
  ident: ref_26
  article-title: Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-019-1496-1
– volume: 10
  start-page: 308
  year: 2020
  ident: ref_27
  article-title: Regulation of integrin subunit Alpha 2 by miR-135b-5p modulates chemoresistance in gastric cancer
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2020.00308
– volume: 68
  start-page: 4447
  year: 2008
  ident: ref_5
  article-title: Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-0249
– volume: 44
  start-page: 170
  year: 2017
  ident: ref_19
  article-title: The role of exosomes in cancer metastasis
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2017.02.006
– volume: 25
  start-page: 234
  year: 2015
  ident: ref_23
  article-title: Integrins and cancer: Regulators of cancer stemness, metastasis, and drug resistance
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2014.12.006
– volume: 4
  start-page: 121
  year: 2018
  ident: ref_13
  article-title: Past, current, and future incidence rates and burden of metastatic prostate cancer in the united States
  publication-title: Eur. Urol. Focus
  doi: 10.1016/j.euf.2017.10.014
– ident: ref_17
  doi: 10.3390/cancers11101418
– volume: 2
  start-page: 22097
  year: 2013
  ident: ref_43
  article-title: Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients
  publication-title: J. Extracell. Vesicles
  doi: 10.3402/jev.v2i0.22097
– volume: 288
  start-page: 17713
  year: 2013
  ident: ref_45
  article-title: Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.445403
– volume: 522
  start-page: 106
  year: 2015
  ident: ref_18
  article-title: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
  publication-title: Nature
  doi: 10.1038/nature14492
– volume: 216
  start-page: 2883
  year: 2019
  ident: ref_47
  article-title: Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20190158
– volume: 32
  start-page: 983
  year: 2014
  ident: ref_29
  article-title: Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes
  publication-title: Stem Cells
  doi: 10.1002/stem.1619
– volume: 86
  start-page: 9906
  year: 1989
  ident: ref_25
  article-title: The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.86.24.9906
– volume: 2015
  start-page: 481493
  year: 2015
  ident: ref_58
  article-title: Extracellular vesicles from caveolin-enriched microdomains regulate hyaluronan-mediated sustained vascular integrity
  publication-title: Int. J. Cell Biol.
  doi: 10.1155/2015/481493
– volume: 226
  start-page: 526
  year: 2018
  ident: ref_59
  article-title: Prognostic role of BRAF(V600E) cellular localization in melanoma
  publication-title: J. Am. Coll. Surg.
  doi: 10.1016/j.jamcollsurg.2017.12.040
– volume: 78
  start-page: 2205
  year: 2018
  ident: ref_22
  article-title: Nuclear receptor LRH-1 functions to promote castration-resistant growth of prostate cancer via its promotion of intratumoral androgen biosynthesis
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-17-2341
– volume: 3
  start-page: 288
  year: 2017
  ident: ref_30
  article-title: Prostate cancer exosomes as modulators of the tumor microenvironment
  publication-title: J. Cancer Metastasis Treat.
  doi: 10.20517/2394-4722.2017.32
– volume: 351
  start-page: 1488
  year: 2004
  ident: ref_7
  article-title: Mechanisms of androgen-refractory prostate cancer
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp048178
– volume: 10
  start-page: 33
  year: 2004
  ident: ref_6
  article-title: Molecular determinants of resistance to antiandrogen therapy
  publication-title: Nat. Med.
  doi: 10.1038/nm972
– volume: 77
  start-page: 41
  year: 2019
  ident: ref_40
  article-title: Prostate cancer sheds the alphavbeta3 integrin in vivo through exosomes
  publication-title: Matrix Biol.
  doi: 10.1016/j.matbio.2018.08.004
– volume: 24
  start-page: 243
  year: 1993
  ident: ref_51
  article-title: Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands
  publication-title: Hum. Pathol.
  doi: 10.1016/0046-8177(93)90033-D
– volume: 15
  start-page: 41
  year: 2016
  ident: ref_2
  article-title: Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: A systematic review
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-016-0523-5
– volume: 13
  start-page: 208
  year: 2014
  ident: ref_38
  article-title: Induction of integrin alpha2 in a highly bone metastatic human prostate cancer cell line: Roles of RANKL and AR under three-dimensional suspension culture
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-13-208
– volume: 6
  start-page: 665
  year: 2010
  ident: ref_11
  article-title: Abiraterone acetate: A promising drug for the treatment of castration-resistant prostate cancer
  publication-title: Future Oncol.
  doi: 10.2217/fon.10.48
– volume: 15
  start-page: 657
  year: 2008
  ident: ref_24
  article-title: Integrins in prostate cancer progression
  publication-title: Endocr. Relat. Cancer
  doi: 10.1677/ERC-08-0019
– volume: 95
  start-page: 1028
  year: 2002
  ident: ref_4
  article-title: Metastatic prostate carcinoma to bone: Clinical and pathologic features associated with cancer-specific survival
  publication-title: Cancer
  doi: 10.1002/cncr.10788
– volume: 8
  start-page: 3
  year: 2009
  ident: ref_50
  article-title: Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer
  publication-title: J. Carcinog.
  doi: 10.4103/1477-3163.48453
– volume: 10
  start-page: 797
  year: 2008
  ident: ref_39
  article-title: Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase
  publication-title: Neoplasia
  doi: 10.1593/neo.08380
– volume: 155
  start-page: 676
  year: 2014
  ident: ref_54
  article-title: Proper application of antibodies for immunohistochemical detection: Antibody crimes and how to prevent them
  publication-title: Endocrinology
  doi: 10.1210/en.2013-1971
– volume: 70
  start-page: 20
  year: 2018
  ident: ref_41
  article-title: Exosomal alphavbeta6 integrin is required for monocyte M2 polarization in prostate cancer
  publication-title: Matrix Biol.
  doi: 10.1016/j.matbio.2018.03.009
SSID ssj0000331767
Score 2.4283395
Snippet Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer...
SourceID pubmedcentral
proquest
gale
crossref
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 2300
SubjectTerms Androgen receptors
Androgens
Cancer cells
Cancer therapies
Castration
Cell adhesion & migration
Cell culture
Cell growth
Cell proliferation
Ectopic expression
Exosomes
Experiments
Health aspects
Lymph nodes
Mesenchyme
Metastases
Metastasis
Methyl-β-Cyclodextrin
Phenotypes
Physiological aspects
Prostate cancer
Proteins
Tumors
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swELcYSGgvaDCmdQPkSXvYSyBxnDh-mqAqgklF1QQSb1H8VZBK0jUFjX-Bv5o71y20Ejz74yzf-X6-8_mOkJ9GZ1wDbkSMKzRQpI4KmShgCOCLi1VSVOga6F_kZ1f8z3V2HRxubQirnOtEr6hNo9FHfsQA13P8ui1_j_9FWDUKX1dDCY0PZANUcAHG18ZJ72Lwd-FliVPAx1zMcvqkYN8fadzMSZsw_8QUL8HRqlJeDZR8hTynn8hWuDLS4xmPt8marXfIZj88in8mT73_Tdvc2Tbq-7ob1lCPQM5OaOPo-XRYMTrwYXe2pf3b4YzptKoNPa8fKvSXYccBfgCB4bTrF0-7djRqqXqkWN4DSA1pb4w_OEYgskCqBfm-ebyDlXlqPvRrl1yd9i67Z1EosRBpLtk0yiutjZXGJYBKDtO9qwx0ZJVoxguTKmGE1oljinEhVGIzJ2JnKi4LAD5pXfqFrNdNbb8SmjOhtBCwWWDhpRmvCq6tkHFhpFRxKjvkcL7TpQ75x7EMxqgEOwRZU66wpkN-LQaMZ6k33u66h6wr8VDCnBqOiC6P8fKVS1BJ0DxnaRmOaFu-CFSH_Fg040gMO6ttc-_75Nxn6esQsSQKixVheu7llvr2xqfpFhzuPkn67X3i38lHhiY8ZtnN9sj6dHJv9-GeM1UHQZifATOjAWM
  priority: 102
  providerName: ProQuest
Title Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition
URI https://www.proquest.com/docview/2435602549
https://www.proquest.com/docview/2436400955
https://pubmed.ncbi.nlm.nih.gov/PMC7466113
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdbC2MvY90Hy9YGDfawF3eWLFvWQxltSNcOXMJYIG_G-nBacO0uTkvzL-yv3p3ipEvoYM-SrLPupN-dPn5HyCdrYmEANwIuNAYoygSpYhoUAvhShpqlBW4NZBfJ2Vh8n8STh3RA3QC2j4Z2mE9qPKsO738tvsKEP8KIE0L2LwbHZ9Yy7k-NIH7fBViSOEuzztf3y3IEUOkzyvJQ8iBJlFhS_Tz2jQ2U2l6rt-9P_gVIpy_Ji86TpMdL1e-RJ65-RZ5l3Vn5a_J7eN-0zbVrg8yn43CWemAq3Yw2JT2fTwtOR_42nmtpdjVd2gItakvP67sCt9Gw4gjfhUBzOvDC04GrqpbqBcWsH9DVlA5v8GFHBZYMXbVg9peLa5DM9-ZvhL0h49Phz8FZ0GVeCIxQfB4khTHWKVsyAKsSWeB1DEtnwQwXqY20tNIYVnLNhZSaubiUYWkLoVLAQ-XK6C3ZqZvavSM04VIbKWGwIPCLYlGkwjipwtQqpcNI9cjhaqRz09GSY3aMKofwBFWTb6mmRz6vG9wsGTn-XXUfVZej9cA3Dcwckx-jT5YoWKmgeKXSfGV4OQchE6QIAMk-rouxJd5Gq11z6-skwpP39YjcMIW1RMjavVlSX1169m4pwCVi0fv__40P5DnHKB-JeON9sjOf3boDcIXmuk92T4YXox998vTbhPW9wf8BZD8MFA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFVSCbggniJQYJFA4mJqr9de7wGhElIltIki1Eq9Ge_DaaXUDnEK5Bf4GL6RmbUdSCS49byPWe28dmbnQcgroyOuQW94jCs0UKT2EhkoQAjol9xXQZKha2A0jgen_NNZdLZDfrW5MBhW2cpEJ6hNqdFHvs9Ar8eYui3fz7962DUKf1fbFho1WRzZ1Xcw2ap3w4-A39eMHfZPegOv6SrgaS7Z0oszrY2VJg9AEOdY4VxFIBayQDOemFAJI7QOcqYYF0IFNsqFn5uMywRkvbR5CPveILs8BFOmQ3Y_9MeTz2uvjh-CPo5FXUMoDKW_rxF5iypg7kvL31B_20pgOzDzL013eJfcaZ6o9KCmqXtkxxb3yc1R8wn_gPzs_yir8tJW3sj1-bCGOo2X2wUtczpcTjNGJy7Mz1Z0dDGtiYxmhaHD4luG_jmcOMGEE1hOe-7wtGdns4qqFcV2IgBqSvtzzBiZAYsAqAr46Xx1CSdz0Fyo2UNyei2X_4h0irKwjwmNmVBaCLgssCjDiGcJ11ZIPzFSKj-UXfK2velUN_XOse3GLAW7B1GTbqGmS96sF8zrUh__nrqHqEtRCMCeGlhSpwf42IsliEAYblGaNiKhSv8QcJe8XA_jSgxzK2x55ebE3FUF7BKxQQrrE2E58M2R4uLclQUXHN5aQfjk_8BfkFuDk9FxejwcHz0ltxm6D7DCb7RHOsvFlX0Gb6ylet4QNiVfrpuXfgMiMz66
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFVSqeKCykukFFgkkLiY2Ou113tAqKSJGkqiCFGpN-N9OK2U2mmcAvkFPomvY2btBBIJbj3vY1Y7r53ZeRDyyuiIa9AbHuMKDRSpvUQGChAC-iX3VZBk6BoYjuKTM_7xPDrfIb9WuTAYVrmSiU5Qm1Kjj7zDQK_HmLotO3kTFjE-7r-fXXvYQQp_WlftNGoSObXL72C-Ve8Gx4Dr14z1e1-6J17TYcDTXLKFF2daGytNHoBQzrHauYpARGSBZjwxoRJGaB3kTDEuhApslAs_NxmXCch9afMQ9r1DdgVYRX6L7H7ojcaf1x4ePwTdHIu6nlAYSr-jEZHzKmDue8vfUIXbCmE7SPMvrdffJ_ea5yo9qunrPtmxxQOyN2w-5B-Sn70fZVVe2cobup4f1lCn_XI7p2VOB4tJxujYhfzZig4vJzXB0awwdFB8y9BXhxPHmHwCy2nXHZ527XRaUbWk2FoEQE1ob4bZI1NgFwBVAW9dLK_gZA6aCzt7RM5u5fIfk1ZRFvYJoTETSgsBlwXWZRjxLOHaCuknRkrlh7JN3q5uOtVN7XNswTFNwQZC1KRbqGmTN-sFs7rsx7-nHiLqUhQIsKcG9tTpET78YgniEIZXKE0b8VClf4i5TV6uh3ElhrwVtrxxc2LuKgS2idgghfWJsDT45khxeeFKhAsO764gPPg_8BdkD3go_TQYnT4ldxl6ErDYb3RIWov5jX0Gz62Fet7QNSVfb5uVfgOY_ELv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes-Mediated+Transfer+of+Itga2+Promotes+Migration+and+Invasion+of+Prostate+Cancer+Cells+by+Inducing+Epithelial-Mesenchymal+Transition&rft.jtitle=Cancers&rft.au=Gaballa%2C+Rofaida&rft.au=Ali%2C+Hamdy+E.+A.&rft.au=Mahmoud%2C+Mohamed+O.&rft.au=Rhim%2C+Johng+S.&rft.date=2020-08-15&rft.issn=2072-6694&rft.eissn=2072-6694&rft.volume=12&rft.issue=8&rft.spage=2300&rft_id=info:doi/10.3390%2Fcancers12082300&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_cancers12082300
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon